Which Indian companies manufacture temozolomide APIs (active pharmaceutical ingredient)?
Based on the information provided, no specific Indian temozolomide API manufacturers can be confirmed. To identify the right suppliers, you typically need a source that lists Indian API producers (for example, DMF holders in India, CDSCO/Drug Master File records, or reputable pharma supplier directories with verified manufacturing sites).
If you share whether you need (a) “temozolomide API” specifically (not finished capsules/tablets) and (b) the grade (e.g., DMF-grade for generics vs. research use), I can help narrow the search criteria you should use.
How to verify an Indian temozolomide API supplier’s legitimacy (DMF, site, and quality)
When sourcing temozolomide API in India, buyers usually check:
- Whether the supplier is listed as a DMF/ASMF holder (or supports your application referencing their file).
- The manufacturing site details (GMP status and the exact site that produces the API).
- Batch documentation expectations (CoA, impurity profile, residual solvents, specification ranges).
- Compliance with regulatory requirements relevant to your market (India CDSCO for domestic filings; EMA/FDA expectations if exporting).
What buyers should clarify before requesting a quote
Temozolomide is a cytotoxic oncology API, so suppliers often need details such as:
- Intended use (pharmaceutical finished dose manufacture vs. lab/R&D use).
- Target strength and dosage-form that your finished product will be made into (so the API grade matches).
- Packaging and supply format (drum vs. bottle, temperature/humidity requirements if applicable).
- Documentation requirements (DMF/COA/analysis method, stability expectations, impurity limits).
Is temozolomide API availability stable in India?
Availability can vary because temozolomide is specialized and cytotoxic. Even when an API supplier exists, lead times can change depending on:
- Campaign-based production (smaller oncology API manufacturing runs).
- Regulatory inspection outcomes at the manufacturing site.
- Whether the supplier is supporting specific customers with DMF-ready material.
If you tell me your quantity range (e.g., 1–10 kg vs. 25–200 kg) and destination market, I can suggest the most practical verification and sourcing approach.
Alternatives if you can’t find a reliable temozolomide API source
If a qualified temozolomide API source isn’t available (or lead times are too long), buyers often consider:
- Contract manufacturing of the finished dosage with an established CMO that already sources compliant API.
- Switching to a partner with established regulatory documentation for oncology APIs.
- Exploring different grade specifications if permitted by your regulatory pathway.
Next step (so I can give you a usable supplier shortlist)
Reply with:
1) Are you sourcing for finished dosage manufacturing or for R&D?
2) Do you need DMF/ASMF-grade API for regulatory filings? (yes/no)
3) Target country for your finished product (India, EU, US, etc.)
4) Approximate annual quantity (or first order quantity)
With that, I can outline the exact checks and search strategy to identify legitimate Indian temozolomide API manufacturers that match your regulatory and quality needs.